Thrombolytic therapy.
D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D007263:Infusions, Parenteral / Q000009:adverse effects / Q000451:nursing*; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*; D013927:Thrombosis / Q000517:prevention & control; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D014568:Urokinase-Type Plasminogen Activator